[PDF][PDF] Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis
M Melo, AG da Rocha, J Vinagre… - J Clin …, 2015 - researchgate.net
TO THE EDITOR: We read with interest the study by Xing et al 1 recently published inJournal
of Clinical Oncology, together with the accompanying editorial. 2 In their large series of …
of Clinical Oncology, together with the accompanying editorial. 2 In their large series of …
[HTML][HTML] BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients
L Jin, E Chen, S Dong, Y Cai, X Zhang, Y Zhou… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The role of telomerase reverse transcriptase (TERT) gene promoter mutations in the
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …
The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A …
B Chen, Y Shi, Y Xu, J Zhang - Clinical endocrinology, 2021 - Wiley Online Library
BRAFV600E mutation is highly prevalent in patients with papillary thyroid carcinoma (PTC),
and TERT promoter (TERTp) mutation is strongly associated with cancer‐related mortality …
and TERT promoter (TERTp) mutation is strongly associated with cancer‐related mortality …
BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
Purpose To investigate the prognostic value of the BRAF V600E mutation and the recently
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …
identified TERT promoter mutation chr5: 1,295,228 C> T (C228T), individually and in their …
Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer
T Trybek, A Walczyk, D Gąsior-Perczak, I Pałyga… - …, 2019 - academic.oup.com
In this study, we examined the relationship between coexisting BRAF V600E and TERT
promoter mutations in papillary thyroid cancer (PTC) and response to therapy. PTC cases …
promoter mutations in papillary thyroid cancer (PTC) and response to therapy. PTC cases …
Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node …
H Ren, Y Shen, D Hu, W He, J Zhou, Y Cao… - Cancer management …, 2018 - Taylor & Francis
Background Mutations of BRAF V600E and TERT promoters are associated with thyroid
cancer development. This study further investigated association of these mutations with …
cancer development. This study further investigated association of these mutations with …
Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma—a meta‐analysis
HG Vuong, AMA Altibi, UNP Duong… - Clinical …, 2017 - Wiley Online Library
Introduction The use of molecular markers, especially BRAF and TERT promoter mutations,
for risk stratification in papillary thyroid carcinoma (PTC) is subject to continuing debate. In …
for risk stratification in papillary thyroid carcinoma (PTC) is subject to continuing debate. In …
[HTML][HTML] Mutations of the TERT promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma
R Liu, Y Li, W Chen, J Cong, Z Zhang… - Oncology …, 2020 - spandidos-publications.com
Several previous studies have shown that mutations in B‑Raf proto‑oncogene (BRAF) and
telomerase reverse transcriptase (TERT) can be used for the diagnosis and prognosis of …
telomerase reverse transcriptase (TERT) can be used for the diagnosis and prognosis of …
Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
S Moon, YS Song, YA Kim, JA Lim, SW Cho, JH Moon… - Thyroid, 2017 - liebertpub.com
Background: The presence of a telomerase reverse transcriptase (TERT) promoter mutation
has been suggested as a potential prognostic marker for thyroid cancer, and a synergistic …
has been suggested as a potential prognostic marker for thyroid cancer, and a synergistic …
[HTML][HTML] BRAF V600E and TERT promoter mutations in papillary thyroid carcinoma in Chinese patients
J Sun, J Zhang, J Lu, J Gao, X Ren, L Teng, H Duan… - PLoS …, 2016 - journals.plos.org
Background The BRAF V600E and telomerase reverse transcriptase (TERT) promoter
mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this …
mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this …
相关搜索
- thyroid carcinoma promoter mutations
- thyroid carcinoma meta analysis
- thyroid cancer braf v600e
- patient prognosis tert promoter
- braf mutations tert promoter
- patient prognosis braf mutations
- predictive value promoter mutations
- thyroid carcinoma predictive value
- thyroid carcinoma patient prognosis
- meta analysis promoter mutations
- tumor aggressiveness promoter mutations
- poor outcomes promoter mutations
- chinese patients braf v600e
- thyroid carcinoma tumor aggressiveness
- thyroid carcinoma poor outcomes
- thyroid carcinoma tert promoter